Showing 141 - 160 results of 237 for search '"National Cancer Institute"', query time: 0.06s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146

    人肿瘤细胞ERCC2 基因表达与抗癌药耐药的相关性 by L

    Published 2001-01-01
    “…【方法】采用Western blo t 检测美国国家癌症研究所(National Cancer Institute , NCI)用于 抗癌药筛选的60 株人肿瘤细胞的ERCC2 表达, 并与170 种抗癌药物的细胞毒试验结果进行相关性分析。…”
    Get full text
    Article
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151

    In Silico Screening, Synthesis and In Vitro Evaluation of Some Quinazolinone and Pyridine Derivatives as Dihydrofolate Reductase Inhibitors for Anticancer Activity by A. G. Nerkar, A. K. Saxena, S. A. Ghone, A. K. Thaker

    Published 2009-01-01
    “…ISB3 (4-(N, N-dimethyl-amino)-phenyl) Schiff''s base derivative of pyridine carbohydrazide showed equipotent activity with the standards used in in vitro anticancer assay as per the NCI (National Cancer Institute) guidelines.…”
    Get full text
    Article
  12. 152
  13. 153
  14. 154
  15. 155

    Impacts of pragmatic implementation science in a primary care laboratory by Nathalie Huguet, Sonja Likumahuwa-Ackman, Heather Holderness, April Lee, Jennifer E. DeVoe

    Published 2025-01-01
    “…The Implementation Science Centers in Cancer Control (ISC3) initiative, funded by the National Cancer Institute, called for the development of implementation laboratories to bolster implementation science, create research-ready environments, and expedite adoption and implementation of evidence-based interventions (EBIs) into practice. …”
    Get full text
    Article
  16. 156
  17. 157

    Impact of Undetected Comorbidity on Treatment and Outcomes of Breast Cancer by Robert I. Griffiths, Michelle L. Gleeson, José M. Valderas, Mark D. Danese

    Published 2014-01-01
    “…Two comorbidity indices were constructed: the National Cancer Institute index, using 12 months of claims before cancer, and a second index for previously undetected conditions, using three months after cancer. …”
    Get full text
    Article
  18. 158
  19. 159
  20. 160

    Age-period-cohort analysis of self-harm incidence rates by gender in Iran among individuals aged 10–39 years, 1990–2019 by Yousef Ramazani, Alireza Abdi, Shahab Rezaeian, Farid Najafi, Zhyla Aliyavari, Mehdi Moradinazar

    Published 2025-01-01
    “…Data was stratified into six age groups and six five-year periods, and analyzed using the APC Web Tool from the National Cancer Institute. The average incidence rates of self-harm attempts and deaths among individuals aged 10–39 years were 93.87 and 7.55 per 100,000 individuals, respectively. …”
    Get full text
    Article